Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.

MLA

Burleigh, Michael E., et al. “Inhibition of Cyclooxygenase with Indomethacin Phenethylamide Reduces Atherosclerosis in ApoE-Null Mice.” Biochemical Pharmacology, vol. 70, no. 3, Aug. 2005, pp. 334–42. EBSCOhost, https://doi.org/10.1016/j.bcp.2005.04.044.

APA

Burleigh, M. E., Babaev, V. R., Patel, M. B., Crews, B. C., Remmel, R. P., Morrow, J. D., Oates, J. A., Marnett, L. J., Fazio, S., & Linton, M. F. (2005). Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice. Biochemical Pharmacology, 70(3), 334–342. https://doi.org/10.1016/j.bcp.2005.04.044

Chicago

Burleigh, Michael E, Vladimir R Babaev, Mayur B Patel, Brenda C Crews, Rory P Remmel, Jason D Morrow, John A Oates, Lawrence J Marnett, Sergio Fazio, and Macrae F Linton. 2005. “Inhibition of Cyclooxygenase with Indomethacin Phenethylamide Reduces Atherosclerosis in ApoE-Null Mice.” Biochemical Pharmacology 70 (3): 334–42. doi:10.1016/j.bcp.2005.04.044.